• The CA Profile was invented for early detection of cancers and for monitoring therapy success. It was found that elevated tumor markers could be detected in the blood several years prior to the time when diagnosis can be made. The Profile is not site or organ specific, however, it will detect metabolic changes leading to or indicating cancer. HCG hormone, PHI enzyme, GGTP enzyme, CEA, TSH, and DHEA-S are the components. The actual, super sensitive cancer markers are HCG (sensitivity 0.3 mIU/mL), PHI and CEA. The other three analytes are peripherally related to malignancies: GGTP monitors the liver and biliary systems, TSH measures low or high thyroid activity, DHEA-S is the adrenal "anti stress, pro-immunity, longevity" hormone. (A low thyroid and/or adrenal activity predisposes to cancer.)

• The CA Profile was positive in 92% of established breast cancer patients, 97% of lung cancer patients, and 93% of colon cancer patients. Statistical studies done on 571 patients with cancers of all sites resulted in 89.8% positives. Our current statistics indicate that 68% of "healthy" American women and 56% of "healthy" American men presnt with elevated tumor markers.They maybe in the process of developing cancer. Note, it may take 10 - 12 years to diagnose.s

The following tumor markers are also available: PSA (prostate), CA 15.3 (breast), CA 125 (ovary), and CA 19.9 (gastric, pancreatic).

For a much broader insight into health, looking at an entire individual rather than only cancer, the Longevity Profile© was designed. This Profile does include the Cancer Profile plus,

• coronary risk markers: homocysteine, hs-CRP, Lp(a), LDL Direct
• sex hormones: estradiol, progesterone, free- and total testosterone
• bone health marker: PTH
• adrenal stress/death hormone: cortisol a.m. and p.m.,
• growth hormone: IGF-1 or somatomedin,
• chemistry profile: sugar, cholesterols, organ enzymes, electrolyte minerals, etc.
• CBC with differential (complete blood count): white cells, red cells, platelets, etc.

• The Longevity Profile together with the Cancer Profile are like a "biochemical fortune telling." The tests will reveal not only existing diseased conditions but also diseases to happen in the future. As one physician put it, "You can tell us in advance what types of diseases our patients may develop. It is marvelous."

  Sincerely,

E.K. Schandl, M.S., Ph.D., [M.D., M.A.], FACB, SC(ASCP), CC(NRCC), LNC, CLD